Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Comparative Effects of Aerobic Exercises and Jacobson's Progressive Relaxation Technique in Primary Dysmenorrhea

1 juin 2026 mis à jour par: Riphah International University

Comparative Effects of Aerobic Exercises and Jacobson's Progressive Relaxation Technique on Pain, Fatigue and Quality of Life in Primary Dysmenorrhea

The study will focus on the comparative effects of aerobic exercises and Jacobson's progressive relaxation technique on pain, fatigue and quality of life in primary dysmenorrhea.

This study will be a randomized clinical trial and will be conducted in, Superior college depalpur and Army public schools and college Lahore (APSACS). Non probability convenience sampling will be used to collect the data.64 participants will be selected on the basis of inclusion and exclusion criteria and will be equally divided into two groups by sealed opaque enveloped .Participants having age group between 17-24 years and diagnosed with WaLiDD score are included.

Aperçu de l'étude

Statut

Recrutement

Les conditions

Intervention / Traitement

Description détaillée

Primary dysmenorrhea (PD) refers to menstrual pain without organic lesions in the pelvic cavity , which mainly manifests as spastic pain and distension above the symphysis pubis in the lower abdomen before and after or during menstruation, radiating to the lumbosacral region and inner thigh. PD is a common gynecological disorder affecting 50%-90% of women. The study will focus on the comparative effects of aerobic exercises and Jacobson's progressive relaxation technique on pain, fatigue and quality of life in primary dysmenorrhea.

This study will be a randomized clinical trial and will be conducted in, Superior college depalpur and Army public schools and college Lahore (APSACS). Non probability convenience sampling will be used to collect the data.64 participants will be selected on the basis of inclusion and exclusion criteria and will be equally divided into two groups by sealed opaque enveloped .Participants having age group between 17-24 years and diagnosed with WaLiDD score are included. Athletes and married women will be excluded. Outcome measures will be taken using Numeric pain rating scale (NPRS) for pain, EQ-5D-5L questionnaire for quality of life, fatigue assessment scale for fatigue. Both Groups will receive same baseline treatment which is core muscle strength. Group A will receive aerobic exercises and Group B will receive Jacobson's progressive relaxation technique for 3 times in a week. The treatment will be given for 8 weeks. Outcome measures will be measured at baseline and after 8 weeks. Data analysis will be done by SPSS version 25.

Type d'étude

Interventionnel

Inscription (Estimé)

58

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

  • Pakistan
    • Punjab Province
      • Okāra, Punjab Province, Pakistan, 52513
        • Recrutement
        • Superior college for women and Polytechnic institute
        • Chercheur principal:
          • Aansa Manzoor, MSWHPT

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Enfant
  • Adulte

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Pain on numeric rating pain scale,
  • Menarche range 12-16,
  • BMI less than 30,
  • Having a regular menstrual cycle (28-32) days,
  • Normal bleeding days (3 to 1) and diagnosed with mild PD according to WaLiDD score

Exclusion Criteria:

  • Athletes,
  • married women with gynaecological abnormalities were excluded,
  • Medical treatment during the study (e.g., oral contraceptives, antidepressants)
  • Recent musculoskeletal trauma or surgery, or chronic musculoskeletal disorders
  • affecting pain perception (e.g., fibromyalgia, pelvic floor dysfunction)
  • secondary dysmenorrhea-related conditions (e.g., endometriosis, fibroids, ovarian cysts),
  • consumption of painkillers
  • No mental or physical diseases, which reduce the abilities to exercise

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Double

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur actif: aerobic exercises
Group A will receive aerobic exercises for 3 times in a week.
Autre: aerobic exercises

Group A Duration of forty five minutes Warm up exercises for 10 minutes. Free active movement of upper limb, lower limb, and upper body, cross toe to touch dynamic stretches such as lunges, Achilles tendon and hamstrings stretching. The aerobic workout duration will be 25mins.. The aerobic exercise involved the following steps with15reps of each exercise and while changing the step slow marching step for 15second and then move towards the next step.

single step touch, double step touch, step touch front and back ,grapevine, knee lift , lunge side and back, L step ,V step, jumping jacks. Cool down exercises for 10 minutes included slow marching, quadriceps and hamstring and stretching. Subjects were prohibited from aerobics during menstruation and data were recorded for two menstrual cycles.
Expérimental: Jacobson's progressive relaxation technique
Group B will receive Jacobson's progressive relaxation technique for 3 times in a week.
Autre: Jacobson's relaxation technique
Group B Jacobson's relaxation technique is a type of therapy that focuses on tightening and relaxing specific muscle groups in a sequence that makes you feel calmer and makes you aware of your body and physical sensations. It is also known as PMRT. (39) JPRT was applied three times a week from the estimated date of ovulation to the onset of the next menstruation. . The participants were in a supine position and were supported with cushions. The JPRT involves participants actively contracting muscles to create tension and then progressively releasing them. First of all, the participants were asked to contract the muscles tightly and hold for slow count of 5seconds (s) and then relax them completely for 10 s. At the same time, the participants practiced diaphragmatic breathing. The participants repeatedly performed JPMRT for each body part. Each session lasted about 20-30 min.
Autres noms:
  • Aerobic exercises and hypopressive

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
WaLlDD relaxation technique on pain, fatigue and quality of life in primary dysmenorrhea.
Délai: 2 months
At baseline, the participant scored at the initial level on the WaLliDD scale, indicating their starting status. Over time, changes in the score reflect improvement or decline in the measured outcome. An increase in score suggests positive progress in the targeted domain, while a decrease indicates reduced functioning or worsening condition compared to baseline.
2 months
Fatigue Assessment Scale
Délai: 2 months
At baseline, the participant's fatigue level is measured using the Fatigue Assessment Scale, providing a starting score of perceived fatigue. Changes in the score over time indicate variation in fatigue severity. A decrease from baseline reflects improvement (reduced fatigue), while an increase indicates worsening fatigue compared to the initial assessment.
2 months
EQ-5D-5-L-Questionnaire
Délai: 2 months
The EQ-5D-5L is a standardized questionnaire used to assess health-related quality of life. It measures five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each rated on five levels of severity. It also includes a visual analog scale (VAS) where individuals rate their overall health. Higher scores indicate better perceived health status.
2 months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Riphah International University

Les enquêteurs

  • Chercheur principal: Hafiza Iqra Rubab, MSWHPT, Riphah International University

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 octobre 2025

Achèvement primaire (Estimé)

1 juillet 2026

Achèvement de l'étude (Estimé)

1 juillet 2026

Dates d'inscription aux études

Première soumission

1 juin 2026

Première soumission répondant aux critères de contrôle qualité

1 juin 2026

Première publication (Réel)

5 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

5 juin 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

1 juin 2026

Dernière vérification

1 juin 2026

Plus d'information

Termes liés à cette étude

Mots clés

Termes MeSH pertinents supplémentaires

Autres numéros d'identification d'étude

  • REC/RCR&AHS/25/0514

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner